Found 8 matching trials
Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults PHASE1 This is a phase 1 study to assess the safety and immunogenicity of differen...
Show More Learn More & Join Trial
Safety and Immunogenicity of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adults With Chronic Immune-Mediated Diseases PHASE3 The purpose of the study is to evaluate the safety and immunogenicity of th...
Show More Location
Medical Centre of Edelweiss Medics LLC
Learn More & Join Trial
Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults PHASE2 This is a phase 2, randomized, controlled, observer-blind study to evaluate...
Show More Location
Multiple Locations
Learn More & Join Trial
SCB-2019 as COVID-19 Vaccine PHASE1 This is a randomized, double blind, placebo controlled, first-in-human (FIH...
Show More Location
Linear Clinical Research Ltd
Learn More & Join Trial
An Observer-blind, Cohort Randomized, Exploratory Phase 3 Study to Evaluate the Safety and Immunogenicity of Recombinant Covid-19 Vaccine, mRNA Covid-19 Vaccine and Recombinant SARS-CoV-2 Trimeric S-protein Subunit Vaccine as 4th Dose in Individuals Primed/ Boosted With Various Regimens PHASE3 This is an exploratory phase 3, cohort randomized, observer-blind, multi-ce...
Show More Location
Centro de Estudos e Pesquisa em Moléstias Infecciosas (CEPCLIN)
Learn More & Join Trial
Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19) PHASE2 SARS-CoV-2 is a highly transmissible and pathogenic coronavirus that emerge...
Show More Location
Hospital de Clínicas de Porto Alegre
Learn More & Join Trial
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19 PHASE2 The purpose of this double-blind, randomized, controlled study is to evalua...
Show More Learn More & Join Trial
Long-term Follow-up to the Phase 1 Study of Adjuvanted SARS-CoV-2 (SCB 2019) Vaccine for COVID-19. PHASE1 To develop an effective vaccine against the Severe acute respiratory syndro...
Show More Location
Linear Clinical Research
Learn More & Join Trial